84th Scientific Sessions Recap Videos—Latest Research on CVD and Diabetes
Panel Discussion – A Multidisciplinary Approach—Challenging Cases from the Cardiometabolic Clinic
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Allen I. White Distinguished Professor, Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences, Washington State University
Discussion on Diabetes and Cardiovascular Disease—Obesity and Diabetes—Innovative Research to Inform Clinical Practice
Dr. Tracey Taveira, PharmD, CDOE
University of Rhode Island
SELECT Trial—New Looks at Glycemia, Inflammation, and Heart Failure
Mark D. Benson, M.D., Ph.D.
Director of Preventive Cardiology at Beth Israel Deaconess Medical Center (BIDMC)
THE STEP-HFpEF and STEP-HFpEF-DM Trials—Targeting Obesity to Treat Heart Failure
Vanita Aroda, M.D.
Director of Diabetes Clinical Research at Brigham and Women’s Hospital
Assoc. Dir. Medicine at Harvard Medical School
AHA Cardiorenal Protection
Chronic kidney disease (CKD) with type 2 diabetes (T2D) is a major public health problem, resulting in significant cardiovascular and kidney adverse outcomes worldwide. Despite the widespread use of standard-of-care therapies for CKD with T2D over the past few decades, rates of progression to end-stage kidney disease remain high with no beneficial impact on its accompanying burden of cardiovascular disease.
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the ADA and the EASD
The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements on the management of hyperglycemia in type 2 diabetes in adults, published since 2006 and last updated in 2019. The target audience is the full spectrum of the professional health care team providing diabetes care in the U.S. and Europe. A systematic examination of publications since 2018 informed new recommenda- tions.
ADA Standards of Care and ACC/AHA Guidelines: Best Practices and Recommendations for CVD Prevention in Patients with T2D
Lifestyle modifications should be implemented as needed to manage weight and to incorporate dietary adjustments.
The American Diabetes Association’s Standards of Care in Diabetes—2024
Watch the Know Diabetes by Heart™ presentation on the Standards of Care in Diabetes—2024 (Standards of Care) from the American Diabetes Association® (ADA). Dennis Bruemmer, MD, PhD, highlights important updates to this year’s Standards of Care and how those changes impact clinical care, especially as they relate to type 2 diabetes, cardiovascular disease (CVD), and chronic kidney disease (CKD).
Date: Friday, January 26, 2024
Time: 1:30 pm
– 2:30 pm ET
Dennis Bruemmer, MD, PhD, Cleveland Clinic
Robert A. Gabbay, MD, PhD, Chief Scientific and Medical Officer, American Diabetes Association
American Heart Association’s Scientific Sessions Highlights: Latest Research on CVD and Diabetes
Date: Wednesday, November 29, 2023
Time: 4:00 pm
– 5:00 pm ET
Watch Know Diabetes by Heart™ for an expert panel discussion on new science released at the American Heart Association’s Scientific Sessions. Panelists will discuss clinical highlights from the 2023 Scientific Sessions related to cardiovascular disease risk management in patients with diabetes, including renal disease. As experts in their field, they will also relate how new findings can be incorporated into clinical practice and how to apply clinically relevant highlights to improve patient outcomes.
Discussion topics include:
- Late-Breaking Science: In Depth with SELECT Trial
- Diabetes and Heart Failure: New Mechanistic Insights and Therapeutics Strategies
- Navigating the Intersection of Cardiovascular, Kidney and Metabolic Health
- Cardiovascular-kidney-metabolic Syndrome Pathophysiology and Therapies
Learning objectives:
- Identify clinical highlights from the 2023 American Heart Association’s Scientific Sessions related to cardiovascular disease risk management in patients with type 2 diabetes.
- Relate how new findings can be incorporated into clinical practice.
- Apply clinically relevant highlights to improve patient outcomes.
Dr. Justin Echouffo Tcheugui, MD, PhD; Johns Hopkins University
Dr. Sadiya Khan, MD, MSc; Northwestern Medicine
Dr. Tiffany Powell-Wiley, MD, MPH; National Institutes of Health
American Diabetes Association’s Standards of Care in Diabetes—2023
Date: Wednesday, February 8, 2023
Time: 2:00 pm
ET
Join Know Diabetes by Heart™ for a presentation on the Standards of Care in Diabetes—2023 (Standards of Care) from the American Diabetes Association® (ADA). Dr. Dennis Bruemmer and Dr. Alexander Chang will highlight important updates to this year’s Standards of Care and how those changes impact clinical care, especially as they relate to type 2 diabetes, cardiovascular disease, and chronic kidney disease.
Learning Objective
Identify the ADA’s 2023 Standards of Care for classifying, diagnosing, preventing, and treating diabetes, cardiovascular disease, and chronic kidney disease.
Dennis Bruemmer, MD, PhD, Cleveland Clinic
Alexander Chang, MD, MS, Geisinger Health
AHA Scientific Sessions Highlights—Latest Research on CVD and Diabetes
Join Know Diabetes by HeartTM for an expert panel discussion on new science released at the American Heart Association’s Scientific Sessions. Panelists will discuss clinical highlights from the 2022 Scientific Sessions related to cardiovascular disease risk management in patients with diabetes, including renal disease. As experts in their field, they will also relate how new findings can be incorporated into clinical practice and how to apply clinically relevant highlights to improve patient outcomes.
Date: Monday, December 5, 2022
Time: 1:00 pm
ET
Learning Objectives:
- Identify clinical highlights from the 2022 AHA Scientific Sessions related to cardiovascular disease risk management in patients with type 2 diabetes.
- Relate how new findings can be incorporated into clinical practice.
- Apply clinically relevant highlights to improve patient outcomes.
Chiadi Ndumele, MD, PhD, MHS (Assistant Professor of Medicine, Johns Hopkins University School of Medicine)
Jane Reusch, MD (Professor of Medicine, Bioengineering and Biochemistry, Associate Director of the Ludeman Family Center for Women’s Health Research at the University of Colorado Anschutz Medical Campus)
Nathan Wong, PhD, MPH, FACC, FAHA, FNLA, FASPC (Professor of Medicine and Director, Heart Disease Prevention Program, University of California, Irvine)
American Diabetes Association 82nd Scientific Sessions Recap–Latest Research on CVD and Diabetes including Renal Risk Management
Join Know Diabetes by Heart for an expert panel discussion on new science released at the 82nd American Diabetes Association’s Scientific Sessions. Panelists will discuss clinical highlights from the 2022 Scientific Sessions related to cardiovascular disease and renal risk management and how to apply these relevant highlights to improve patient outcomes.
Date: Monday, June 27, 2022
Time: 4:00 pm
– 5:00 pm ET
Learning Objectives:
At the end of this activity, you will be able to:
- Recall clinical highlights from the 2022 Scientific Sessions related to cardiovascular disease and renal risk management.
- Identify applications of new findings to clinical practice that can improve patient outcomes.
Sanjay Kaul, MD, FACC, FAHA (Professor of Medicine, Cedars-Sinai Medical Center)
Neda Rasouli, MD (Professor of Medicine, University of Colorado)
2022 American Diabetes Association Standards of Care
Join Know Diabetes by Heart™ for a presentation on the Standards of Medical Care in Diabetes—2022 (Standards of Care) from the American Diabetes Association® (ADA).
Date: Wednesday, February 2, 2022
Time: 4:00 pm
– 5:00 pm ET
Join Know Diabetes by Heart™ for a presentation on the Standards of Medical Care in Diabetes—2022 (Standards of Care) from the American Diabetes Association® (ADA). Dr. Nuha El Sayed will highlight important updates to this year’s Standards of Care and how those changes impact clinical care, especially as they related to type 2 diabetes and cardiovascular disease.
Learning Objectives:
- Identify the ADA’s 2022 Standards of Care for classifying, diagnosing, and treating diabetes and cardiovascular disease.
Nuha Ali El Sayed, MD, MM Sc., Vice President, American Diabetes Association and Instructor in Medicine, Harvard Medical School
